Abreos Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Abreos Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10945
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information for the personalized treatment of multiple sclerosis using natalizumab. The company developed a veritope technology platform to identify proprietary peptide-based ligands that can measure and purify biologic molecules. Its Veritopes can be customized for use in multiple formats including sandwich ELISA for the direct tracking of blood concentrations of biologic drugs. Abreos offers custom reagents to biopharmaceutical manufacturers and researchers for drug development life cycle; pharmacokinetic studies; bio-purification; and personalized dosing of biologic drugs. Abreos is headquartered in San Diego, California, the US.

Abreos Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abreos Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Abreos Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Abreos Biosciences Raises USD1.2 Million in Financing 11
Abreos Biosciences Raises USD0.1 Million in Venture Financing 12
Abreos Biosciences Raises USD0.7 Million in Seed Financing 13
Abreos Biosciences Raises USD0.2 Million in Venture Financing 14
Partnerships 15
Abreos Biosciences and Institut Paoli-Calmettes Enter into Research Collaboration 15
Licensing Agreements 16
Abreos Biosciences Enter into License Agreement with University of California San 16
Abreos Biosciences Inc – Key Competitors 17
Abreos Biosciences Inc – Key Employees 18
Abreos Biosciences Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abreos Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abreos Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Abreos Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Abreos Biosciences Raises USD1.2 Million in Financing 11
Abreos Biosciences Raises USD0.1 Million in Venture Financing 12
Abreos Biosciences Raises USD0.7 Million in Seed Financing 13
Abreos Biosciences Raises USD0.2 Million in Venture Financing 14
Abreos Biosciences and Institut Paoli-Calmettes Enter into Research Collaboration 15
Abreos Biosciences Enter into License Agreement with University of California San 16
Abreos Biosciences Inc, Key Competitors 17
Abreos Biosciences Inc, Key Employees 18

List of Figures
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Abreos Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Abreos Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Systemair AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Systemair AB Mergers and Acquis …
  • Scottish Power Ltd:企業の発電所・SWOT分析2018
    Scottish Power Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Gulf Cement Company P.S.C:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Gulf Cement Company P.S.C" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • Omeros Corp (OMER):製薬・医療:M&Aディール及び事業提携情報
    Summary Omeros Corp (Omeros) is a biopharmaceutical company that discovers, develops and commercializes small-molecule and protein therapeutics for large-market and orphan indications. The company’s pipeline products include Omidria, a phenylephrine and ketorolac injection for use during cataract su …
  • Repros Therapeutics Inc (RPRX):企業財務及び戦略的SWOT分析
    Summary Repros Therapeutics Inc (Repros), formerly Zonagen, Inc is a biopharmaceutical company that develops new drugs to treat hormonal and reproductive system disorders. The company’s product pipeline includes enclomiphene and proellex. Its enclomiphene is an orally active proprietary small molecu …
  • MOL Hungarian Oil and Gas Public Limited Company (MOL):企業のM&A・提携動向(エネルギー分野)
    Summary MOL Hungarian Oil and Gas Public Limited Company (MOL) is an integrated global oil and gas company. It carries out the exploration and production of crude oil, natural gas and other gas products. It conducts refining, transportation and storage of crude oil; wholesale and retail marketing of …
  • Cellnovo Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cellnovo Ltd (Cellnovo), formerly Starbridge Systems Ltd is a provider of conventional diabetes care technology solutions. The company offers mobile diabetes management systems such as insulin patch pump, cellular-enabled wireless touchscreen handset with integrated blood glucose meter, acti …
  • Huron Consulting Group Inc.:企業のM&A・提携・投資分析
    Huron Consulting Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huron Consulting Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Pardus Oil & Gas LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Pardus Oil & Gas LLC (Pardus Oil & Gas), formerly Energy & Exploration Partners LLC, is an oil and gas exploration and development company that acquires, explores, develops and produces onshore unconventional oil and natural gas assets in East Texas. The company operates oil and liquids-rich …
  • Mymetics Corporation (MYMX):企業の財務及び戦略的SWOT分析
    Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Camfin S.p.A:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Camfin S.p.A Mergers and Acquis …
  • Fonar Corporation (FONR):企業の財務及び戦略的SWOT分析
    Summary Fonar Corporation (Fonar) is a medical device company that develops, produces and markets medical scanning equipment. The company’s products include the upright MRI, Fonar 360 and the open sky MRI. Fonar’s products are used for detection and diagnosis of human diseases. It provides solutions …
  • MediBeacon Inc:企業の製品パイプライン分析2018
    Summary Medibeacon Inc (Medibeacon) is a provider of critical information solutions to improve patient acre. The company offers real time kidney function monitoring solutions. It offers the renal function system that helps clinicians with the continuous monitoring of the kidney. Medibeacon also prov …
  • Energisa SA (ENGI11):電力:M&Aディール及び事業提携情報
    Summary Energisa SA (Energisa) is a power utility that generates, distributes and sells electricity. The company generates electricity through wind, small hydropower, and biomass resources. It also operates and maintains hydroelectric power plants for other companies; constructs and refurbishes gene …
  • Icon Acquisition Holdings, L.P.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Icon Acquisition Holdings, L.P. …
  • Barracuda Networks, Inc.:企業の戦略・SWOT・財務情報
    Barracuda Networks, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barracuda Networks, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Groupe Steria SCA (Inactive):企業の戦略・SWOT・財務分析
    SummaryGroupe Steria SCA (Inactive) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Grand Parade Investments Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Grand Parade Investments Limite …
  • Benefitfocus, Inc. (BNFT):企業財務及び戦略的SWOT分析
    Summary Benefitfocus, Inc. (Benefitfocus) is a benefit technology service provider that offers web-based platform for shopping, enrolling, managing and exchanging benefit information for employers, insurance carriers and consumers. The company’s platform provides plan shopping, consumer engagement a …
  • International Brachytherapy s.a.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' International Brachytherapy s.a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆